Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: AJNR Am J Neuroradiol. 2017 May 11;38(7):1297–1302. doi: 10.3174/ajnr.A5188

Table 4.

Frequency of adverse events using various contrast media from the literature and our data

Adverse events Severe adverse events
Gadolinium25 0.8% 0.03%
Iodinated (ionic)26 12.66% 0.22%
Iodinated (non-ionic)26 3.13% 0.04%
Ferumoxytol (Feraheme® label) 3.7% 0.2%
Ferumoxytol (our data) 10.6% 0%